LENSAR, Inc. (LNSR)

$6.41

-0.10 (-1.54%)
Rating:
Recommendation:
-
Symbol LNSR
Price $6.41
Beta 0.000
Volume Avg. 0.01M
Market Cap 70.413M
Shares () -
52 Week Range 5.502-8.98
1y Target Est -
DCF Unlevered LNSR DCF ->
DCF Levered LNSR LDCF ->
ROE -30.79% Strong Sell
ROA -28.51% Sell
Operating Margin -
Debt / Equity 21.05% Neutral
P/E -
P/B 1.28 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest LNSR news


Mr. Nicholas T. Curtis
Healthcare
Medical Devices
NASDAQ Capital Market

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.